Annual Current Liabilities
$6.98 M
+$798.00 K+12.90%
December 31, 2023
Summary
- As of February 7, 2025, NVCT annual total current liabilities is $6.98 million, with the most recent change of +$798.00 thousand (+12.90%) on December 31, 2023.
- During the last 3 years, NVCT annual current liabilities has risen by +$6.97 million (+69740.00%).
- NVCT annual current liabilities is now at all-time high.
Performance
NVCT Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$6.32 M
+$546.00 K+9.46%
September 30, 2024
Summary
- As of February 7, 2025, NVCT quarterly total current liabilities is $6.32 million, with the most recent change of +$546.00 thousand (+9.46%) on September 30, 2024.
- Over the past year, NVCT quarterly current liabilities has increased by +$740.00 thousand (+13.27%).
- NVCT quarterly current liabilities is now -9.56% below its all-time high of $6.98 million, reached on December 31, 2023.
Performance
NVCT Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NVCT Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.9% | +13.3% |
| 3 y3 years | +10000.0% | +13.3% |
| 5 y5 years | +10000.0% | +13.3% |
NVCT Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +188.7% | -9.6% | +161.1% |
| 5 y | 5-year | at high | >+9999.0% | -9.6% | +1523.7% |
| alltime | all time | at high | >+9999.0% | -9.6% | +1523.7% |
Nuvectis Pharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.32 M(+9.5%) |
| Jun 2024 | - | $5.77 M(+1.4%) |
| Mar 2024 | - | $5.69 M(-18.5%) |
| Dec 2023 | $6.98 M(+12.9%) | $6.98 M(+25.3%) |
| Sep 2023 | - | $5.58 M(+21.0%) |
| Jun 2023 | - | $4.61 M(+17.2%) |
| Mar 2023 | - | $3.93 M(-36.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $6.19 M(+155.7%) | $6.19 M(+37.7%) |
| Sep 2022 | - | $4.49 M(+64.1%) |
| Jun 2022 | - | $2.74 M(-10.5%) |
| Mar 2022 | - | $3.06 M(+26.5%) |
| Dec 2021 | $2.42 M(>+9900.0%) | $2.42 M(+388.7%) |
| Sep 2021 | - | $495.00 K(+27.2%) |
| Jun 2021 | - | $389.00 K |
| Dec 2020 | $10.00 K | - |
FAQ
- What is Nuvectis Pharma annual total current liabilities?
- What is the all time high annual current liabilities for Nuvectis Pharma?
- What is Nuvectis Pharma annual current liabilities year-on-year change?
- What is Nuvectis Pharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly current liabilities year-on-year change?
What is Nuvectis Pharma annual total current liabilities?
The current annual current liabilities of NVCT is $6.98 M
What is the all time high annual current liabilities for Nuvectis Pharma?
Nuvectis Pharma all-time high annual total current liabilities is $6.98 M
What is Nuvectis Pharma annual current liabilities year-on-year change?
Over the past year, NVCT annual total current liabilities has changed by +$798.00 K (+12.90%)
What is Nuvectis Pharma quarterly total current liabilities?
The current quarterly current liabilities of NVCT is $6.32 M
What is the all time high quarterly current liabilities for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly total current liabilities is $6.98 M
What is Nuvectis Pharma quarterly current liabilities year-on-year change?
Over the past year, NVCT quarterly total current liabilities has changed by +$740.00 K (+13.27%)